ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
US Tech 100
16,983.60
0.00%
Dow Jones
37,815.92
-1.49%
Brent Oil
85.425
-0.55%
Bitcoin
59,047.98
-2.56%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Zymeworks Inc (ZYME) Quote

Zymeworks Inc

Zymeworks Inc (ZYME)

NASDAQ
8.58
0.00
(0.00%)
Closed May 01 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
8.58
Bid
8.32
Ask
8.65
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
453.754M
Previous Close
8.58
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
70,568,222
Dividend Yield
-
PE Ratio
-3.82
Earnings Per Share (EPS)
-1.68
Revenue
76.3M
Net Profit
-118.67M

About Zymeworks Inc

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.zymeworks.com
Headquarters
North Vancouver, British Columbia, Can
Founded
1970
Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZYME. The last closing price for Zymeworks was $8.58. Over the last year, Zymeworks shares have traded in a share price range of $ 0.00 to $ 0.00.

Zymeworks currently has 70,568,222 shares outstanding. The market capitalization of Zymeworks is $453.75 million. Zymeworks has a price to earnings ratio (PE ratio) of -3.82.

ZYME Latest News

More News

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

21 hours ago
GlobeNewswire Inc.

Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

April 11 2024
GlobeNewswire Inc.

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

April 08 2024
GlobeNewswire Inc.

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

March 28 2024
GlobeNewswire Inc.

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

March 27 2024
GlobeNewswire Inc.

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

March 07 2024
Edgar (US Regulatory)

Form RW - Registration Withdrawal Request

March 07 2024
Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933

March 06 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CGCCanopy Growth Corporation
$ 14.89
(78.97%)
83.58M
AKLIAkili Inc
$ 0.39
(66.03%)
86.48M
GVVisionary Holdings Inc
$ 0.256
(60.00%)
2.18M
GMMGlobal Mofy Metaverse Ltd
$ 1.47
(58.01%)
80.37M
IMCCIM Cannabis Corporation
$ 0.88
(57.14%)
13.14M
CETXCemtrex Inc
$ 1.1499
(-35.40%)
575.64k
LICNLichen China Limited
$ 1.32
(-34.98%)
1.28M
BCLIBrainstorm Cell Therapeutics Inc
$ 0.3731
(-30.86%)
1.74M
NRXPNRX Pharmaceuticals Inc
$ 2.60
(-26.76%)
937.63k
HWHHWH International Inc
$ 1.92
(-25.58%)
3.96M
TLRYTilray Brands Inc
$ 2.475
(39.83%)
154.33M
SQQQProShares UltraPro Short QQQ
$ 11.95
(5.66%)
129.32M
TSLATesla Inc
$ 183.28
(-5.55%)
127.04M
JAGXJaguar Health Inc
$ 0.2146
(3.17%)
100.27M
EGOXNext e GO NV
$ 0.0307
(11.23%)
95.14M

Discussion

View Full Feed
Urocka Urocka 4 minutes ago
Thanks for the laugh sir....
GDVM
rikkie rikkie 7 minutes ago
Hé PUMPKIN , you were here 10 years ago bashing LWLG.
The share was then at 0.5 $. Now 10 years later the share is worth 4$ and you are still here to bash LWLG. Are you normal in mind and is help from a psychologist not recommended here? I want to help you, you know, and I'm so sorry!
LWLG
NotSure2 NotSure2 7 minutes ago
Reporting issuers are required to publicly disclose any material changes to their affairs. A material change (for a reporting issuer other than an investment fund) is either: a change in the business, operations, or capital of a company that would have a significant effect on the market price or val
NWBO
One11 One11 9 minutes ago
Goondale has come.
MGON
snow snow 12 minutes ago
RD I have a question regarding the two series of tokens. Recently there has been some information about a valuation of 27 dollars per token which I assume relates to the other series than the one we are owners own. Our series are utility tokens? The value of our tokens will of course more or less de
ITUP
DanM51 DanM51 13 minutes ago
Lol, I haven't "twisted the statements of Lightwave's competitors". I think you're feeling pressure. Just remember, when we get all the gains from lwlg "pretty soon" you just put that money into your other gem, Niocorp.
LWLG
236T568 236T568 14 minutes ago
and....heeee iiiiiisssss back!

https://nypost.com/wp-content/uploads/sites/2/2024/05/george-santos-1.jpg?resize=741,1024&quality=75&strip=all
pepeoil pepeoil 15 minutes ago
This chit isn’t going anywhere
UNRG
pepeoil pepeoil 15 minutes ago
Loaded more of these cheapies man,
XOM
pepeoil pepeoil 17 minutes ago
My only winner of the day. Lol. I love this stock but hate the company.
PGR
dale1953 dale1953 17 minutes ago
That site is run by Anthony Powers, who is paid by a lot of the mining companies. Since Marathon is not 1 of his sponsors, his views towards MARA are usually not that great. If you click on that link then you will see a list of the companies that he says trust his analysis. Marathon is not on the l
MARA
NotSure2 NotSure2 20 minutes ago
Surely do, more than you:

In 2023 you kept saying "soon" "soon" "soon"... multiple times about SP going to the moon , shareholders will be "millionaires" etc...

-You are claiming NWBO submit for whatever combo, not DCVAX-L. (when they clearly PR ed DCVax-L).
NWBO
Ppastis Ppastis 23 minutes ago
Well said !!!!
This ‘ thing ‘ is a disgrace for this board !!!
Moderator time for action !
LWLG
fuagf fuagf 24 minutes ago
rooster, I know your SCOTUS said it was ok to lie in public, that doesn't mean
we're gonna let you lie here as much as you have today. Get the message.
RuudSaltis RuudSaltis 26 minutes ago
I think that your post is offensive and discriminating. Please remove this poster and put him on the bench for long. Many poster have been punished for less!
LWLG
VST7 VST7 31 minutes ago
They will Dump til there's NO BID..Then do a Massive Reverse Split...

I would Not Buy/Hold ANY of this POS...
MJLB
dstock07734 dstock07734 33 minutes ago
beartrap12,
Thanks for the post.

My speculation is that the approval could be about DCVax-L + poly-iclc based on RWD/RWE with guidance about the combination concerning keytruda. There is no SEC requirement about public disclosure of drug application. I suspect the approval shou
NWBO
littlejohn littlejohn 34 minutes ago
SBUX seemed to have a solid miss...

https://stocktwits.com/wallstengine/message/571333945

Question isn't the economy...

How does a coffee selling company

miss in a winter quarter?...

Too many working and not enough to
joev2 joev2 34 minutes ago
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318274217&type=HTML&symbol=SINT&cdn=9f52f4cba97f149e09d7019a4a363463&companyName=SiNtx+Technologies+Inc.&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2024-04-30
SINT
CoinOp CoinOp 38 minutes ago
I have discovered you have not done much DD on EBET, you can't even follow the lawsuit stages we are in .

Last Docket #59 was on 4/11, it was also the first Docket that needed to be sealed, no more motions out there left pending to delay going to trial , which means DISCOVERY phase c
EBET
Dodger1 Dodger1 44 minutes ago
$AABB

GO AABB!
AABB
DR_rugby DR_rugby 46 minutes ago
And full access to the IRS tax code

Write downs

https://m.youtube.com/watch?v=hSy8kIF8Plg

The ground is shifting right under our feet

Also

MJ is a cash heavy industry that when changes happens

They can dep
SNDL

Your Recent History

NASDAQ
ZYME
Zymeworks
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved